首页 >
法规速递
-
Document: CHMP PROM minutes for the meeting on 14 April 2025-2025/8/19
2025-08-20查看详情 > -
Page: PRAC recommendations on safety signals-2025/9/29
2025-09-30查看详情 > -
Document: On-boarding of users to Substance, Product, Organisation and Referentials (SPOR) data services-2025/11/5
2025-11-06查看详情 > -
Document: Consultation on an ancillary medicinal substance incorporated in a medical device - Gynemed GmbH & Co. KG HSA-containing ART media-2025/12/4
2025-12-05查看详情 > -
Document: Guiding principles of good AI practice in drug development-2026/1/14
2026-01-15查看详情 > -
Document: Concept paper for the revision of the guideline on veterinary good pharmacovigilance practices (VGVP) Module: Signal Management (EMA/522332/2021)-2026/2/13
2026-02-14查看详情 > -
Document: Recommendations of the Executive Steering Group on the Shortages and Safety of Medicinal Products on shortages of intravenous ifosfamide and cyclophosphamide-2026/3/24
2026-03-25查看详情 > -
国家药监局药审中心关于发布《药审中心外聘专家增补名单(2025年第三批)》的通告(2026年第31号)-2026/4/29
2026-04-30查看详情 > -
儿童用药口感设计与评价的技术指导原则(试行)-2022/11/2
2022-11-14查看详情 > -
Regulatory and procedural guideline: Biologics Working Party (BWP) Ad hoc Influenza Working Group - Amended European Union recommendations for the seasonal influenza vaccine composition for the season 2023/2024-2023/4/3
2023-04-06查看详情 >